Loading...
Stiripentol add‐on therapy for focal refractory epilepsy
BACKGROUND: This is an updated version of the Cochrane review last published in 2015 (Issue 10). For nearly 30% of people with epilepsy, seizures are not controlled by current treatments. Stiripentol is a new antiepileptic drug (AED) that was developed in France and was approved by the European Medi...
Na minha lista:
| Udgivet i: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley & Sons, Ltd
2018
|
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6494649/ https://ncbi.nlm.nih.gov/pubmed/29747241 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD009887.pub4 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|